BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Clinical - Pre-Clinical
Calithera Biosciences, Inc. (CALA) Reports Fourth Quarter And Full Year 2014 Financial Results And Recent Highlights 3/27/2015
BioBlast Pharma (ORPN) Announces Positive Preclinical Proof-Of-Concept Results Of Its Novel Mitochondrial Protein Replacement Platform In Friedreich's Ataxia 3/26/2015
Tekmira (TKMR) Presents Preclinical Results Demonstrating Super-Additive Effects On Plasma Triglyceride Lowering By Silencing Of Apoc3 And ANGPTL3 Genes 3/26/2015
Genisphere's 3DNA Drug Delivery Platform Achieves Success In Preclinical Treatment Of Posterior Capsular Opacification (PCO) 3/26/2015
Arch Therapeutics Announces Favorable Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device Versus A Popular Cellulose-Based Hemostatic Agent 3/25/2015
AvidBiotics Release: Study Published In mBio Shows That Avidocin Proteins Prevent Clostridium Difficile Infection In Mice Without Harming Protective Gut Bacteria 3/24/2015
New Data Supporting Arno Therapeutics' HDAC Inhibitor AR-42 Published In The Journal of Urology 3/24/2015
Conatus Pharmaceuticals Inc. And BioReliance Corporation Present Key Emricasan Preclinical Safety Results At Society Of Toxicology Annual Meeting 3/24/2015
Batu Biologics Publishes Preclinical Data For ValloVax 3/20/2015
Kineta Inc.’s SHK-186 Shows Encouraging Early Results As Potential Therapy For Autoimmune Eye Diseases 3/19/2015
Assay Depot, Inc. Creates Preclinical Innovation Marketplace For AstraZeneca PLC (AZN) 3/19/2015
Sangui BioTech International Inc. (SGBI): Series Of Preclinical Trials Concluded Successfully 3/18/2015
Blueprint Medicines Publishes Preclinical Proof-Of-Concept Data On Promising New Therapy For Patients With Genomically Defined Hepatocellular Carcinoma 3/16/2015
Synthetic Biologics Reports Year End 2014 Financial Results And Operational Highlights 3/16/2015
BioLineRx Ltd.’s Treatment for Type 1 Diabetes Effective In Preclinical Trials 3/11/2015
Greenovation Biotech GmbH Successfully Completes Preclinical Toxicology Studies Of Alpha - Galactosidase 3/10/2015
Regeneus (RGS.AX) (ASX:RGS) Positive Preclinical Results For Progenza 3/9/2015
Biothera's Investigational Cancer Immunotherapy Imprime PGG Neutralizes Cancer Defense Mechanisms In The Tumor Mircoenvironment 3/9/2015
Horizon Pharma plc.  (HZNP) Announces That Pre-Clinical Data Show Treatment With Interferon Gamma Improved Signs Of Disease Severity Of Rare Bone Disease 3/9/2015
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present Preclinical Data On The Combination Of REOLYSIN And Radiotherapy In Melanoma At The Irish Association For Cancer Research Conference 3/5/2015
N8 Medical Release: Recently Published Study Demonstrates That CSA-90 May Promote Osteogenesis And Prevent Staphylococcus Aureus Infection In Preclinical Models 3/4/2015
Sirona Biochem: Positive Preclinical Toxicology Results For Its SGLT2 Inhibitor Trigger Milestone Payment From Wanbang Biopharmaceuticals 3/4/2015
CohBar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-c And Its Role In Metabolic Regulation 3/4/2015
Momenta Pharmaceuticals, Inc. (MNTA) Announces Publication Revealing Development Of A Novel Process To Generate High-Quality Hyper-Sialylated IVIg Drug Candidate In PNAS 3/3/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/3/2015
Pharmacyclics (PCYC) Release: In Pre-Clinical Studies Ibrutinib Enhances Anti-tumor Activity When Combined With An Anti-PD-L1 Antibody 3/2/2015
Cohbar, Inc. Announces Publication Of Preclinical Proof-Of-Principle Of MOTS-C And Its Role In Metabolic Regulation 3/2/2015
Alkermes plc (ALKS) Announces New Drug Candidate, ALKS 7119, For Treatment Of Alzheimer's Agitation, Depression And Other CNS Diseases 3/2/2015
Gilead (GILD) Announces Preclinical Data For An Investigational TLR7 Agonist In SIV-Infected, Virally Suppressed Monkeys 2/26/2015
Bayer HealthCare (BAY) Strikes Deal With Mission Bay Incubator Tenant Aronora 2/25/2015
Lixte Biotechnology's Lead Compound Reported To Be Active Against Hematologic Cancers In Pre-Clinical Studies 2/25/2015
Nature Neuroscience Publishes Data Demonstrating Potential Therapeutic Benefits Of Karyopharm Therapeutics (KPTI)'s SINE Compounds In The Treatment Of Multiple Sclerosis 2/24/2015
Celsion Corporation (CLSN) Presents Clinical And Preclinical Data For GEN-1 IL-12 Immunotherapy In Ovarian Cancer At The Molecular Medicine TRI-Conference 2/20/2015
Pharmacyte Biotech Initiates Expanded Follow-Up Study In The United States On The Accumulation Of Malignant Ascites Fluid 2/19/2015
Addex Therapeutics (ADXN.SW) mGluR2 NAM Demonstrates Protection In Preclinical Model Of Ischemic Neuronal Death 2/19/2015
Vaccinex, Inc. Announces The Publication Of Data Demonstrating Preclinical Efficacy In An Animal Model Of Huntington Disease 2/18/2015
Significant Findings In NIH's Trial Of Pluristem Therapeutics (PSTI)'s PLX-R18 Cells For Treatment Of Acute Radiation Syndrome 2/18/2015
Anatara Lifesciences Reports Successful DetachTM Trial Results 2/18/2015
Aerie Pharmaceuticals, Inc. (AERI) Announces Potential Breakthroughs With New Preclinical Research 2/18/2015
Halozyme Therapeutics, Inc. (HALO) Announces Preclinical Study Results Of Pegph20 Published In Molecular Cancer Therapeutics 2/17/2015
Tiny Startup Spyryx Looks to One-Up Vertex Pharmaceuticals (MA) (VRTX) With One-Size-Fits-All Cystic Fibrosis Therapy 2/13/2015
Despite CEO's Comments, Experimental Sarepta (SRPT) Drug Protects Lab Monkeys From Ebola 2/11/2015
12635 E. Montview Blvd. Release: Preclinical Melioidosis Results Presented At The 2015 ASM Biodefense And Emerging Diseases Research Meeting In Washington, DC 2/11/2015
Iomet Pharma Demonstrates Superior In Vivo PK/PD Properties In Pre-Clinical IDO, TDO And Dual IDO/TDO Cancer Immunotherapy Programs 2/11/2015
Heat Biologics Presents Positive Preclinical Data On A Novel Approach To Combination Immunotherapy At The Keystone Symposia On Tumor Immunology 2/11/2015
BIOCEO15: ContraFect (CFRXU) CEO Says Lysin, AB Anti-Infectives Are “Game-Changers” in 2015 2/10/2015
Amicus Therapeutics, Inc. (FOLD) Presents Preclinical Data On Next-Generation Pompe ERT At Worldsymposium 2015 2/10/2015
Two of Roche (RHHBY)'s Experimental Parkinson's Drugs Caused Lung Toxicity in Monkeys 2/9/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces The Publication Of Preclinical Data For Supinoxin (RX-5902) Demonstrating Mechanism Of Action 2/9/2015
Hemispherx Biopharma (HEB) Posts USAMRIID Ebola Study Concluding Ampligen Produced 100% Survival Rate In Rodents With 100% Mortality In Placebo 2/9/2015
VBL Therapeutics (VBLX) To Present Preclinical Data At Keystone Symposium On Liver Metabolism And Nonalcoholic Fatty Liver Disease 2/9/2015
Lycera Announces Research Showing Promising Anti-Cancer Activity Of Novel, Oral Immunotherapy Candidates 2/9/2015
Anavex (AVXL) Confirms Positive Preclinical Epilepsy Data For ANAVEX 2-73 - Validation As Potential Platform Drug For Multiple Neurodegenerative Diseases 2/9/2015
Hemispherx Biopharma (HEB): US Army Scientists (USAMRIID) Find Ampligen(R) Produces 100% Survival Rate In Ebola Virus Rodent Study 2/2/2015
Pharmacyte Biotech Initiates First Preclinical Study Of Its Encapsulated Cell Product For Novel Treatment Of Diabetes 2/2/2015
The Journal Diabetes Publishes Pre-Clinical Data On Cortendo’s Novel Diabetes Treatment, BP-2001 1/28/2015
Can-Fite BioPharma (CFBI)'s CF602 Demonstrates Efficacy In Treatment Of Sexual Dysfunction In Preclinical Studies 1/27/2015
Vaccinex, Inc. Announces Groundbreaking Preclinical Data Demonstrating An Immunomodulatory Role For Anti-SEMA4D Antibody Blockade In Colon And Breast Cancer 1/27/2015
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015
MYOS (MYOS)'s Preclinical Study Of Fortetropin's™ Mechanism Of Action Demonstrate Regulatory Effects On Three Key Muscle Health Pathways 1/26/2015
RestorGenex Announces Presentation Of Scientific Data On RES-529 For The Treatment Of Glioblastoma At Keystone Symposia On PI 3-Kinase Signaling Pathway 1/23/2015
Peer-Reviewed Glioma Surgery Study With Cellectar Biosciences  (NVLT) Fluorescence Cancer-Targeting Agents Chosen For The Cover Of Neurosurgery 1/22/2015
Dry Eye Syndrome: Neuroptis Biotech Successfully Completes The Pre-Clinical Phase For ML7 1/21/2015
PsychoGenics Inc. Obtains A License To The McGill Universityl-R-Thy1-APP Rat Model Of Alzheimer’s Disease 1/21/2015
Karcinolys’ Myb34.5 Oncolytic Virus Preclinical Results In Pancreatic Cancer Featured In Peer-Reviewed Journal "Human Gene Therapy" 1/21/2015
Verastem, Inc. (VSTM) Announces Publication Of Scientific Data For VS-5584 In Cancer Research 1/16/2015
Hemispherx Biopharma (HEB) Release: Low Natural Killer (NK) Activity Observed Across The Chronic Fatigue Syndrome (CFS) Disease Spectrum 1/12/2015
Dicerna Pharmaceuticals (DRNA) Presents Positive Preclinical Data On Its DsiRNA Therapeutics Targeting MYC And ?-Catenin At American Association for Cancer Research MYC: From Biology To Therapy Meeting 1/12/2015
PHARNEXT's Pleotherapy Shows Synergistic Effects With PXT-864 In Alzheimer's Disease Through Preclinical Data Published In Nature's Scientific Reports 1/8/2015
Bio-Path Holdings, Inc. (BPTH)’ Liposomal Grb-2 Featured In Peer-Reviewed Journal “Expert Opinion On Drug Delivery” 1/7/2015
Minerva Neurosciences, Inc. (NERV) Reports Positive Data Showing An Analog Of Minerva's MIN-301 Compound Improves Symptoms Of Parkinson's Disease In Primates 1/6/2015
Rexahn Pharmaceuticals, Inc. (RNN) Announces Publication Of Preclinical Data For RX-3117 Demonstrating Effectiveness Against Gemcitabine Resistant Human Cancer Cells 1/6/2015
Novartis AG (NVS) Researchers Claim to Have Discovered "Fountain of Youth" Drug 1/5/2015
Biocryst Pharmaceuticals (BCRX) Announces Study Results For BCX4430 In A Non-Human Primate Model Of Ebola Virus Infection 12/23/2014
Bio-Path Holdings, Inc. (BPTH) To Initiate Development Of Liposomal Bcl-2 In Follicular Lymphoma 12/22/2014
Medivir AB (MVRBF): MIV-802 Has Been Selected As A Candidate Drug And Enters Non-Clinical Development For The Treatment Of Hepatitis C Infection 12/22/2014
PTC Therapeutics, Inc. (PTCT) Release: Translarna Granted Orphan Drug Designation In The U.S. And Europe For The Treatment Of Mucopolysaccharidosis I 12/19/2014
Canopus BioPharma, Inc. Announces Positive Results From An In-Vitro Live Ebola Virus Study 12/19/2014
Nuvilex (NVLX) Provides Shareholder Update On Cancer And Diabetes Programs 12/16/2014
Novogen Limited (NVGN) Announces Breakthrough Discovery In The Treatment Of Melanoma 12/16/2014
Vaccinex, Inc. Announces Publication Of Preclinical Studies With An Anti-SEMA4D Antibody In Animal Models Of Neuroinflammatory And Demyelinating Disease 12/12/2014
Enzyme Bio-Systems Ltd. Release: Preclinical Xenograft Studies Show Positive Results For Amooranin 12/11/2014
Syros Pharmaceuticals Announces New Research Published On CDK7 In Lung And Pediatric Cancers 12/11/2014
NIH Publishes Results Of Preclinical Collaboration With ChromaDex, Inc. Showing Potential Benefit Of Nicotinamide Riboside 12/10/2014
Celator Pharmaceuticals, Inc. Presents Data On CPX-351 At The 56th American Society of Hematology Annual Meeting 12/10/2014
Kadmon Corporation Presents Preclinical Data On KD025 In Chronic Graft-Versus-Host-Disease At American Society of Hematology Annual Meeting 12/10/2014
Aptose Biosciences Presents APTO-253 Preclinical Data At 56th American Society of Hematology Annual Meeting 12/9/2014
Fate Therapeutics (FATE) Highlights Effects Of Nutrient-Rich Media On Ex Vivo Programmed CD34+ Cells Sourced From Umbilical Cord Blood 12/9/2014
GlycoMimetics, Inc. (GLYC) Highlights Potential Therapeutic Benefits Of Its Novel E-Selectin Antagonist At 56th American Society of Hematology Annual Meeting 12/9/2014
Epizyme (EPZM) First-In-Class PRMT5 Inhibitor Demonstrates In Vitro And In Vivo Activity In Models Of Mantle Cell Lymphoma 12/9/2014
Fate Therapeutics (FATE) Unveils Preclinical Findings Of Newly-Identified Small Molecule Modulator Combination For Ex Vivo Programming Of Mobilized Peripheral Blood 12/8/2014
Blueprint Medicines Debuts Comprehensive Preclinical Data Set On First Selective Drug For Patients With Systemic Mastocytosis At 2014 American Society of Hematology Annual Meeting 12/8/2014
Geron Corporation (GERN) Announces Publication Of Preclinical Data On Imetelstat Activity In Acute Myelogenous Leukemia 12/8/2014
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014
Aduro Biotech Announces Preclinical Data Presented At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/4/2014
Xenetic Biosciences Announces OncoHist™ Preclinical Data To Be Featured In A Poster Presentation At The American Society of Hematology Annual Meeting 12/4/2014
ARMGO Pharma Inc. And Servier Announce Advancement Of Rycal ARM210/S48168 Into Clinical Stage Program Targeting Duchenne Muscular Dystrophy 12/4/2014
ZIOPHARM Oncology, Inc. (ZIOP.OB) And Intrexon Corporation Present Clinical And Preclinical Data From Immuno-Oncology Programs At Intrexon Corporation Tumor Immunology And Immunotherapy Meeting 12/4/2014
Idera Pharmaceuticals, Inc. (IDRA) Announces Cancer Immunotherapy Regimen With Intratumoral IMO-2055 Demonstrated Potent And Systemic Anti-Tumor Activity In Preclinical Models 12/3/2014
Preclinical Data Published On AM-Pharma Holding BV’s recAP To Treat Ultra Rare Disease Hypophosphatasia 12/2/2014
AB Science (AB.PA) Advances Ultra-Selective SYK Kinase Inhibitor Into Full Preclinical Development 12/1/2014
Antibe Therapeutics Inc. Provides Update On Its Acute Pain Drug ATB-352 11/25/2014
Luoxis Announces Presentation Of Multiple Studies Validating Redoxsys As A Rapid And Non-Invasive Means Of Assessing Oxidative Stress 11/24/2014
Inovio Pharmaceuticals (INO) Melanoma DNA Immunotherapy Inhibits Tumor Growth And Increases Survival In Preclinical Study 11/20/2014
Nektar Therapeutics (CA) (NKTR) Presents Preclinical Study Findings For Etirinotecan Pegol (NKTR-102) In Combination With A PARP Inhibitor In BRCA1-Deficient Cancer Model 11/20/2014
Kolltan Pharmaceuticals Inc. Presents KTN3379 Clinical And Preclinical Data At International Cancer Meeting 11/20/2014
Deciphera Pharmaceuticals Presents Data On Altiratinib (DCC-2701), An Advanced Multi-Targeted Kinase Inhibitor, At 26th EORTC-NCI-AACR Symposium On Molecular Targets And Cancer Therapeutics 11/20/2014
Cardioxyl Pharmaceuticals HNO Prodrugs Show Effectiveness In Preclinical Models Following Oral Administration, Improve Hemodynamics In Chronic Diastolic Dysfunction 11/20/2014
Nuvilex (NVLX) Announces Preliminary Data From Preclinical Study of Effects of Its Pancreatic Cancer Treatment on Ascites Fluid Formation 11/19/2014
Kadmon Corporation Presents Preclinical Data On Bi-Functional Anti-PD-L1/IL-15 Fusion Protein At EORTC-NCI-AACR Symposium 11/19/2014
Arch Therapeutics Reports Positive Preclinical Data From Study of AC5 Surgical Hemostatic Device™ In Animals Treated With Brilinta® (ticagrelor) 11/18/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data On RNAi Therapeutic Programs For Cardio-Metabolic Diseases At American Heart Association Scientific Sessions 2014 11/18/2014
Regulus Therapeutics, Inc. (RGLS) And Sanofi (SAN.PA) Present New Data Enhancing The Preclinical Profile Of RG-012, An Anti-Mir Targeting Microrna-21 For The Treatment Of Renal Dysfunction In Alport Syndrome Patients, At ASN's Kidney Week 2014 Meeting 11/17/2014
Enzyme Bio-Systems Ltd. Announces An Independent Research Group Reported Breast Cancer Preventive Efficacy For A Novel Synthetic Triterpenoid 11/17/2014
DelMar Pharmaceuticals Presents Preclinical Data Supporting VAL-083 As A Potential New Treatment In Glioblastoma At The Society Of Neuro-Oncology Annual Meeting 11/14/2014
AstraZeneca PLC (AZN) To Test Whether It Can Undo Effects Of Its Own Heart Drug Brilinta 11/13/2014
AstraZeneca PLC (AZN) Announces Initiation of Development Program For BRILINTA (ticagrelor) Reversal Agent 11/13/2014
AM-Pharma Holding BV Presents Preclinical Data On Mode-Of-Action For recAP In Acute Kidney Injury At American Society of Nephrology Meeting 11/13/2014
Cortice Biosciences Announces Results From Studies Evaluating Pipeline Candidates TPI 287 And CRT 001 In Preclinical Models Of Tauopathies And Alzheimer's Disease 11/12/2014
Preclinical Data For GenVec Inc. (GNVC)'s RSV Vaccine Candidate Presented At The 9th RSV Symposium 11/11/2014
SanguiBioTech GmbH: Preclinical Trials Demonstrate: Sangui Hemoglobin Preparation Improves Oxygen Supply Of Vital Organs 11/11/2014
TetraLogic Pharmaceuticals (TLOG) Announces Results Of Preclinical Studies In Hepatitis B 11/10/2014
Ablynx (ABLYF) To Present Pre-Clinical Proof-Of-Concept Results With Anti-Rsv Nanobody, Alx-0171, At 9th International Respiratory Syncytial Virus Symposium 11/6/2014
Xencor Provides Data Updates On XmAb Bispecific Antibody Programs And Announces Presentations At Upcoming American Society of Hematology 2014 Annual Meeting 11/6/2014
Innovimmune Biotherapeutics, Inc. To Present Superior Preclinical Therapeutic Efficacy Results In Rheumatoid Arthritis Of Its INV-17 ROR Gamma T Inhibitor Program At The 2014 American College of Rheumatology Annual Meeting 11/5/2014
Innate Pharma (IPH.PA ) : IPH4102 Preclinical Data Published In "Cancer Research" 11/3/2014
AB Science (AB.PA): Publication Of Preclinical Data On The Neuroprotective Effect Of Masitinib 10/31/2014
Loxo Oncology (LOXO) To Present Pre-Clinical Data On LOXO-101 At Upcoming European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 10/30/2014
CytRx Corporation (CYTR) Announces Publication Of Preclinical Glioblastoma Data In Neoplasia 10/29/2014
Celsion Corporation (CLSN) Presents Preclinical Data For Its TheraSilence™ Platform At The miRNA World Conference Workshop On miRNA Delivery 10/29/2014
FDA Grants Kamada Ltd. (KMDA) Orphan Drug Designation For The Treatment Of Graft Versus Host Disease 10/29/2014
Ebola Clinical Trials: Big Name Players In The Ebola Race 10/28/2014
Celladon Corporation Announces Publication Of Data From Its Stem Cell Factor Gene Therapy Program In Circulation Heart Failure 10/27/2014
Profectus BioSciences, Inc. Receives Department Of The Army Funding For Studies Directed Toward The Development Of A VesiculoVax™ rVSV-Vectored Vaccine For Ebola And Marburg Viruses 10/22/2014
Profectus BioSciences, Inc. Receives $8.6 Million HHS Contract To Accelerate Ebola Vaccine Into Human Clinical Studies 10/22/2014
Immunovaccine Inc. Demonstrates Protection Against Lethal Anthrax Challenge With Rapid Acting, Single Dose Vaccine 10/21/2014
Omeros Corporation (OMER) Suspends Enrollment In Huntington's Disease Trial; Stock Down 11.36% At 8:40AM ET On Tuesday 10/21/2014
VG Life Sciences, Inc. (VGLS) Release: New Data Implicate Components Of Adaptive Immunity In Traumatic Brain Injury 10/20/2014
Epizyme (EPZM) Presents Pre-Clinical Data On EZH2 Inhibitor EPZ-6438 (E7438) In Models Of Synovial Sarcoma 10/17/2014
Sihuan Pharmaceutical Sends Ebola Drug JK-05 To Africa, Eyes Clinical Trials 10/16/2014
Tekmira (TKMR) Presents Results Of Preclinical Studies With Hepatitis B Therapeutic 10/16/2014
Cellular Biomedicine Group (CBMG) Launches Pre-Clinical Research Study For Chronic Obstructive Pulmonary Disease (COPD) 10/16/2014
BioSpecifics Technologies Corporation (BSTC) Announces Presentation Of Encouraging Preclinical Data For CCH From Collaborative Uterine Fibroid Study With Duke Medicine 10/16/2014
HHS Contracts With Profectus BioSciences, Inc. To Manufacture Ebola Vaccine For Animal Safety Studies 10/16/2014
Dicerna Pharmaceuticals (DRNA) Presents Preclinical Data For Investigational RNAi Therapeutic DCR-PH1 In Primary Hyperoxaluria Type 1 (PH1) At The 10th Annual Meeting Of The Oligonucleotide Therapeutics Society 10/15/2014
Alnylam Pharmaceuticals (ALNY) Presents New Clinical And Pre-Clinical Data On RNAi Therapeutics At 10th Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014
Regulus Therapeutics, Inc. Presents New Preclinical Data On Multiple Programs And Provides Portfolio Overview At 10th Annual Oligonucleotide Therapeutics Society (OTS) Meeting 10/14/2014
Mologen AG (MOLGF.PK) Presents EnanDIM: A New Generation Of Immunomodulators 10/14/2014
Compugen Ltd. (CGEN) Achieves Second Preclinical Milestone In Cancer Immunotherapy Collaboration With Bayer AG (BAYZF) 10/14/2014
Tekmira (TKMR) To Present HBV Pre-Clinical Data At Meeting Of The Oligonucleotide Therapeutics Society 10/10/2014
Shionogi, Inc. Release: Novel Siderophore Cephalosporin S-649266 Pre-Clinical Results Suggest Potent Activity Against Multidrug-Resistant Gram-Negative Pathogens 10/9/2014
Kadimastem Received A Quick Response From The FDA: The Development Process For The Stem Cell-Based Drug For ALS Is Expected To Be Significantly Shortened 10/7/2014
Protein Sciences Corporation Expects To Begin Testing Ebola Vaccine 10/7/2014
Kadimastem Approached The FDA Regarding Its ALS Treatment 10/6/2014
Immunovaccine Inc. To Provide Update On Ongoing Ebola Virus And Cancer Vaccine Programs At 13th Annual Biotechnology Industry Organization (BIO) Investor Forum 10/6/2014
3-V Biosciences To Present Clinical And Preclinical Data For FASN Inhibitors At EORTC-NCI-AACR 2014 10/2/2014
Regen BioPharma Completes Preclinical Experiments For dCellVax Breast Cancer Immune Therapy 10/2/2014
REGENXBIO's NAV® Technology Demonstrates Correction Of Cardiovascular Symptoms Of MPS I In Animal Model 9/30/2014
OncoMed Pharmaceuticals, Inc. (OMED) Announces Selection Of First Small Molecule Product Candidate Targeting The Wnt Pathway Under Collaboration With Bayer Pharma AG 9/30/2014
Cell Reports Publication On The Mechanism Of Action Of NOXXON’s Anti-SDF-1 Spiegelmer® Olaptesed Pegol (NOX-A12) In Preclinical Multiple Myeloma Models 9/26/2014
Novartis AG (NVS) Studies Muscle Atrophy By Sending Mice Into Space 9/23/2014
OxThera, Inc. Release: Oxabact® Granted European Medicines Agency Orphan Drug Designation For Treatment Of SBS 9/23/2014
Sirona Biochem Launches Anti-aging Preclinical Studies 9/23/2014
Research Findings Demonstrate miRagen Therapeutics’ Drug Reverses Pulmonary Fibrosis 9/22/2014
Hemispherx Biopharma (HEB) Announces Primate Research Showing Alferon® LDO Protection From Pulmonary Damage Associated With Infection By Highly Pathogenic Influenza Virus 9/22/2014
Nektar Therapeutics (CA) (NKTR) Presents Positive Preclinical Data On Oral, Peripherally-Acting Kappa Agonist Molecules At 2014 American Academy Of Pain Management Meeting 9/19/2014
Cyclacel Pharmaceuticals, Inc. (CYCC)'s CYC065 CDK Inhibitor Demonstrates Therapeutic Potential In Acute Leukemias With Mixed Lineage Leukemia (MLL) Rearrangements 9/18/2014
BioLineRx Ltd. Presents Positive Preclinical Results In Treatment For AML Patients With FLT3 Mutations 9/17/2014
Alnylam Pharmaceuticals (ALNY) Presents New Pre-Clinical Data With ALN-CC5, A Subcutaneously Administered Rnai Therapeutic Targeting Complement Component C5 In Development For The Treatment Of Complement-Mediated Diseases 9/16/2014
Celator Pharmaceuticals, Inc. Announces Publication Of Preclinical Data For CPX-351 In Acute Lymphoblastic Leukemia Models 9/15/2014
Viamet Pharmaceuticals Receives Orphan Drug Designation For VT-1129 9/11/2014
GlaxoSmithKline (GSK)'s Experimental Ebola Vaccine Protects Monkeys For 10 Months 9/8/2014
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) And Hartford Hospital Demonstrate Delafloxacin's Potent In-Vitro Activity Against Complicated Urinary Tract Infection Pathogens 9/8/2014
Blueprint Medicines Presents Positive Data On BLU-554 For Hepatocellular Carcinoma 9/8/2014
Shionogi & Co., Ltd. Presents Pre-Clinical And Phase I Results For S-649266, A Novel Siderophore Cephalosporine Antibiotic With Potential To Treat Multidrug-Resistant Gram-Negative Pathogens 9/8/2014
Novan Therapeutics’s Nitric Oxide Drug Candidate Inhibits Growth Of Papillomavirus In Translational Animal Model 9/8/2014
Arch Therapeutics Announces Positive Preclinical Data From An Independent Study Of AC5 Surgical Hemostatic Device™ 9/8/2014
Melinta Therapeutics (Formerly known as Rib-X Pharmaceuticals, Inc.) Demonstrates Potent In Vitro Activity Of New Antibiotic Class Against Gram Negative ESKAPE Pathogens 9/8/2014
Johnson & Johnson (JNJ) Jumps Into The Ebola Race With Collaboration Of Crucell (JNJ) And Bavarian Nordic (BAVA.CO); Human Trials To Start In Early 2015 9/4/2014
Tricida Announces In-House Discovered Clinical Candidate In Cardiorenal Disease 9/4/2014
Sirona Biochem Announces Positive Results In PK Study For Type 2 Diabetes 9/4/2014
GamaMabs Pharma SA Announces Two Scientific Communications On Its AMHR2 Project 9/4/2014
Rhizen Pharmaceuticals S.A. To Present Preclinical Data Of Their First-In-Class Inflammation Assets, RP6503 And RP3128 For Treatment Of Various Respiratory Diseases 9/3/2014
Chimerix, Inc. (CMRX)'s Brincidofovir Has In Vitro Activity Against Ebola 9/3/2014
Aerpio Announces Publication Of Preclinical Data On AKB-9778 For Common Eye Diseases 9/3/2014
Galleon Pharmaceuticals, Inc. Announces Publication Of Proof-Of-Concept Clinical Studies For GAL-021, Projected Use For The Emerging Perioperative Sleep Apnea Epidemic 9/2/2014
SAGE Therapeutics Presents New Preclinical Data On SAGE-217 At Eilat Conference On New Anti-Epileptic Drugs 9/2/2014
Biocryst Pharmaceuticals (BCRX) Expected To Jump Into Ebola Race In A Few Weeks 8/29/2014
IntelliPharmaCeutics Augments Its Rexista™ Oxycodone Development Program With Novel Overdose Deterrence Technology 8/29/2014
Cannabis Science Inc. Provides Updated Guidance On Its Current Pre-Clinical Drug Development Programs Beginning With The Scientific Cannabis Cultivation Programs In Europe And North America, Testing Multiple Cannabis Strains For Multiple Critical Ailments 8/27/2014
TetraLogic Pharmaceuticals (TLOG) To Present Data From Pre-Clinical Studies With Hepatitis B At The 2014 International Meeting On Molecular Biology Of Hepatitis B Viruses 8/27/2014
REGENX Biosciences, LLC: Attacking A Rare Disease At Its Source With Gene Therapy 8/27/2014
Arch Therapeutics Announces Positive Preclinical Data From Its Study Of AC5 Surgical Hemostatic Device™ In Animals On Blood Thinner 8/25/2014
INSYS Therapeutics Receives FDA Orphan Drug Designation For Its Pharmaceutical Cannabidiol As A Potential Treatment For Glioblastoma Multiforme 8/25/2014
Ebola Vaccine Using Immunovaccine Inc.’s DepoVax Proves Highly Efficacious In Non-Human Primate Study 8/25/2014
Ebola-Like Virus Beaten By Tekmira Pharmaceuticals Corporation (TKMR) Drug In Study 8/22/2014
Nuvilex (NVLX) Begins Preclinical Studies With Translational Drug Development To Determine If Nuvilex's Unique Cancer Treatment Can Slow Accumulation Of Malignant Ascites Fluid 8/20/2014
Stemedica International Announces Pre-clinical Data Of Its Alzheimer’s Study 8/20/2014
Novan Therapeutics To Present Antiviral Preclinical Results Of Nitric Oxide-Releasing Drug Candidates For The Treatment Of Papillomavirus 8/14/2014
Nuvilex (NVLX) Provides Update On Status Of Preclinical Studies At Translational Drug Development 8/13/2014